Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Japan | 2022

The Japanese GI endoscopy device market was impacted negatively by the COVID-19 global pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. The market is expected to recover through 2031 with a moderate growth mainly due to the efficiency of nationwide CRC and GI cancer screening programs and high incidence of gastric cancer and CRC cases in the country; however, ASP decline in some segments and lack of product innovation will limit growth opportunities.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…